Literature DB >> 29503838

Dissimilarity in the Frequency of Venous Thromboembolism Risk Factors among Studies, a Commentary.

Meghdad Sedaghat1, Mahsa Soltani1, Mehrdad Solooki2.   

Abstract

Entities:  

Year:  2018        PMID: 29503838      PMCID: PMC5827045     

Source DB:  PubMed          Journal:  Emerg (Tehran)        ISSN: 2345-4563


× No keyword cloud information.
Dear Editor; Venous Thromboembolism (VTE) is the 3rd most prevalent vascular disease behind myocardial infarction and cerebrovascular ischemic attack (1). This disorder has received attention from health policy makers because of its major complications including recurrent VTE, post thrombotic syndrome, sudden cardiac death and high mortality rate (2). In the United States, VTE was reported in approximately 201000 cases annually, 25% of which expired within 7 days after diagnosis and 22% of mortalities did not have a definitive diagnosis. Despite the progression in diagnosis and treatment of VTE since 1979, its incidence did not decrease dramatically. This gap declares that VTE risk factors, especially transient ones, have not been detected completely (3). Obesity, history of VTE, family history of VTE, recent surgery, malignancy, myeloproliferative disorders, trauma, pregnancy, post-menopausal hormone therapy, hereditary syndromes like anti phospholipid syndrome (APS), chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), blood transfusion and older age are determined as major risk factors. These factors can be categorized into two major subgroups as intrinsic and predisposing. Recent investigations focused on predisposing ones, which can be justified (2, 4). Designing a cross sectional study in Imam Hossein Hospital, Tehran, Iran, from 2016 to 2017, we found that inactivity due to disability (30.9%), smoking (29.3%), and active malignancy (18.1%), were the most prevalent transient risks factor of VTE in our sample, respectively. Similar to our results, Kesieme et al. (5) and Cushman et al. (2) declared that VTE is more diagnosed in the elderly. Park MS et al. (3) introduced recent surgery, trauma (73%), and disability to walk (62%) as major independent risk factors of VTE. Fuji T et al. (6) introduced malignancy, recent infectious disease, and obesity as the factors predisposing patients who were admitted for orthopedic surgery to VTE. As can be seen, despite the risk factors of VTE being the same in various studies, their frequency varied between the studies. Population and cultural characteristics and various habits may have an effect in this regard. Therefore, it is suggested to perform a multi-center, comprehensive study considering all the racial and ethnic in order to have a correct pattern of the frequency of predisposing factors of this disease in the Iranian population for health and prevention programs.
  8 in total

1.  Comparison of long-term outcomes of 50 and 100 mg rt-PA in the management of acute pulmonary thromboembolism.

Authors:  Elif Yilmazel Ucar; Omer Araz; Bugra Kerget; Nafiye Yilmaz; Metin Akgun; Leyla Saglam
Journal:  Clin Respir J       Date:  2017-11-09       Impact factor: 2.570

Review 2.  Epidemiology and risk factors for venous thrombosis.

Authors:  Mary Cushman
Journal:  Semin Hematol       Date:  2007-04       Impact factor: 3.851

3.  Impact of Classical Risk Factors for Arterial or Venous Thrombosis in Patients With Antiphospholipid Syndrome.

Authors:  Daniel Navarro-Carpentieri; Maria Del Carmen Castillo-Hernandez; Karim Majluf-Cruz; Guillermo Espejo-Godinez; Paola Carmona-Olvera; Manuel Moreno-Hernandez; Yolanda Lugo-García; Jesús Hernandez-Juarez; Luis Loarca-Piña; Irma Isordia-Salas; Abraham Majluf-Cruz
Journal:  Clin Appl Thromb Hemost       Date:  2017-09-08       Impact factor: 2.389

4.  Risk factors for venous thromboembolism after acute trauma: A population-based case-cohort study.

Authors:  Myung S Park; Sarah E Perkins; Grant M Spears; Aneel A Ashrani; Cynthia L Leibson; Christine M Boos; William S Harmsen; Donald H Jenkins; Kent R Bailey; Karla V Ballman; John A Heit
Journal:  Thromb Res       Date:  2016-03-29       Impact factor: 3.944

Review 5.  Epidemiology, Pathophysiology, Stratification, and Natural History of Pulmonary Embolism.

Authors:  Nicholas J Giordano; Paul S Jansson; Michael N Young; Kaitlin A Hagan; Christopher Kabrhel
Journal:  Tech Vasc Interv Radiol       Date:  2017-07-05

6.  Deep vein thrombosis: a clinical review.

Authors:  Emeka Kesieme; Chinenye Kesieme; Nze Jebbin; Eshiobo Irekpita; Andrew Dongo
Journal:  J Blood Med       Date:  2011-04-29

7.  Incidence of venous thromboembolism and bleeding events in patients with lower extremity orthopedic surgery: a retrospective analysis of a Japanese healthcare database.

Authors:  Takeshi Fuji; Masao Akagi; Yasuyuki Abe; Eisei Oda; Daisuke Matsubayashi; Kaori Ota; Masafumi Kobayashi; Yasuyuki Matsushita; Jumpei Kaburagi; Kei Ibusuki; Atsushi Takita; Mikio Iwashita; Takuhiro Yamaguchi
Journal:  J Orthop Surg Res       Date:  2017-04-04       Impact factor: 2.359

8.  Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial.

Authors:  Chen Wang; Zhenguo Zhai; Yuanhua Yang; Qi Wu; Zhaozhong Cheng; Lirong Liang; Huaping Dai; Kewu Huang; Weixuan Lu; Zhonghe Zhang; Xiansheng Cheng; Ying H Shen
Journal:  Chest       Date:  2009-09-09       Impact factor: 9.410

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.